Free CME from PeerView


Pulmonary/Respiratory Medicine CME

Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium
Professor Andrew Menzies-Gow
May 04, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
Jacob Sands, MD
April 27, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC
Mark A. Socinski, MD
April 20, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
How I Think, How I Treat—Assessing, Managing, and Engaging Patients With Uncontrolled, Moderate to Severe Asthma: Comparing Approaches With Experts Around the World
Michael E. Wechsler, MD
April 12, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD
March 23, 2022
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD
March 22, 2022
Purvi S. Parikh, MD, FACP, FACAAI/Cedric Jamie Rutland, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Taking It From the Top: Targeting a New Approach to Controlling Severe Asthma
Purvi S. Parikh, MD / FACP, FACAAI/Cedric "Jamie" Rutland, MD
March 17, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
Nasser Altorki, MD / Jonathan D. Spicer, MD / PhD, FRCSC
February 22, 2022
Pasi A. Janne, MD, PhD
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
Pasi A. Janne, MD, PhD
February 22, 2022
Stephen V. Liu, MD
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Visual Exploration of the Possibilities for Macrocyclic TKIs in Treatment-Naive and Pretreated Fusion-Positive NSCLC and Other Tumors
Stephen V. Liu, MD
February 18, 2022
Boris Sepesi, MD, Tina Cascone, MD, PhD
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Bringing Precision Oncology to Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way: What Thoracic Surgeons Need to Know and Do
Boris Sepesi, MD / Tina Cascone, MD / PhD
January 31, 2022
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Expert Perspectives on Improving Early Recognition of Eosinophilic Esophagitis and Examining the Potential Clinical Utility of Emerging Targeted Therapy
Amal H. Assa'ad, MD
December 14, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
David R. Jones, MD
November 19, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?
Jonathan W. Goldman, MD
November 18, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Era in Treatment for Eosinophilic Esophagitis: Expert Insights on the Latest Advances in Targeted Therapy
Ikuo Hirano, MD
November 12, 2021
Credits: 1 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
Covering All the Bases in SSc-ILD Care: Expert Strategies for Diagnosis, Treatment, and Managing Comorbidities
Lorinda Chung, MD, MS
November 11, 2021
Credits: 1 CME / MOC / CC
Medical Learning Institute, Inc.
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Lynette M. Sholl, MD
October 29, 2021
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Fulfilling a Need in the Management of Patients With Eosinophilic Esophagitis: An Exploration of Novel and Emerging Therapeutic Options
Evan S. Dellon, MD, MPH
October 23, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Heart Failure Society of America
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Daniel Jacoby, MD
October 01, 2021
Credits: 0.25 CME
Johns Hopkins University School of Medicine
Advances in the Management of IBD: Expert Insight on What’s New and What’s Next
Aline Charabaty, MD, AGAF, FACG
September 29, 2021
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Jared Weiss, MD
September 29, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD
September 29, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Milind Javle, MD
September 28, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe Asthma
Ian Pavord, FMedSci
September 27, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD
September 15, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Overcoming Challenges in the Management of Moderate to Severe Atopic Dermatitis: Practical Strategies for Selecting Treatment for Pediatric and Adult Patients
Peter A. Lio, MD
September 07, 2021
Credits: 1 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
September 02, 2021
Credits: 0.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Examining Novel Approaches to Improve the Management of Influenza: An Animated Exploration
Charles Vega, MD, FAAFP
July 21, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView